Search Results 271-280 of 15783 for pharmacogenetics
2013 Dec 1; 591(Pt 23):5805-6. View PubMed; Beatty NC, Nicholson WT, Langman LJ, Curry TB, Eisenach JH. Pharmacogenetic workup of perioperative serotonin ...
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics. 1998 Dec; 8(6): ...
The purpose of this study is to find the gene mutations and metabolism dysfunctions that appear to cause the physical disorders of people who have Familial ...
After completing standard-of-care (SOC) CDI antibiotics for their most recent CDI recurrence, patients who meet all eligibility requirements will be randomized ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The purpose of this study is to collect genetic material from individuals belonging to families with high prevalence of Type 1 Diabetes and perform whole exome ...
The purpose of this study is to evaluate the performance characteristics of RNA sequencing. To investigate the utility of RNA analysis in diagnosis of patients ...
Hereditary BRCA-related breast and ovarian cancer, Lynch syndrome and familial hypercholesterolemia are estimated to be relatively prevalent in the general ...
The primary purpose of the LTFU is to assess the long-term safety and tolerability of LX2006 up to 5 years post-treatment. Additionally, efficacy assessments ...
Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.